60
Views
7
CrossRef citations to date
0
Altmetric
Review

Advances in the molecular genetics of ocular coloboma

&
Pages 209-227 | Published online: 09 Jan 2014

References

  • Onwochei BC, Simon JW, Bateman JB, Couture KC, Mir E. Ocular colobomata. Surv. Ophthalmol.45, 175–194 (2000).
  • Snell RS, Lemp MA. Development of the eye and the ocular appendages. In: Clinical Anatomy of the Eye. Blackwell Science, London, UK, 1–21 (1998).
  • Ozanics V, Jacobiec FA. Prenatal development of the eye and its adnexa. In: Ocular Anatomy, Embryology and Teratology. Jacobiec FA (Ed.). Harper and Row, PA, USA, 11–96 (1982).
  • Chang L, Blain D, Bertuzzi S, Brooks BP. Uveal coloboma: clinical and basic science update. Curr. Opin. Ophthalmol.17, 447–470 (2006).
  • Gregory-Evans CY, Williams MJ, Halford S, Gregory-Evans K. Ocular coloboma: a reassessment in the age of molecular neuroscience. J. Med. Genet.41, 881–891 (2004).
  • Warburg M. Classification of microphthalmos and coloboma. J. Med. Genet.30, 664–669 (1993).
  • Morrison D, FitzPatrick D, Hanson I et al. National Study of Microphthalmia, Anophthalmia, and Coloboma (MAC) in Scotland: investigation of genetic aetiology. J. Med. Genet.39, 16–22 (2002).
  • Pagon RA. Ocular coloboma. Surv. Ophthalmol.25, 223–236 (1981).
  • Hornby SJ, Adolph S, Gilbert CE, Dandona L, Foster A. Visual acuity in children with coloboma: clinical features and a new phenotypic classification system. Ophthalmology107, 511–520 (2000).
  • Blackmon DM, Lambert SR. Congenital iris coloboma repair using a modified McCannel suture technique. Am. J. Ophthalmol.135, 730–732 (2003).
  • Uemura A, Uto M. Bilateral retinal detachment with large breaks of pars plicata associated with coloboma lentis and ocular hypertension. Jpn J. Ophthalmol.36, 97–102 (1992).
  • Barber AN. Embryology of the Human Eye. CV Mosby, MO, USA, 50–63 (1955).
  • Shaikh S, Trese M. Infantile choroidal neovascularisation associated with choroidal coloboma. Retina23, 585–586 (2003).
  • Daufenbach DR, Ruttum MS, Pulido JS, Keech RV. Chorioretinal colobomas in a pediatric population. Ophthalmology105, 1455–1458 (1998).
  • Gopal L, Badrinath SS, Kumar KS, Doshi G, Biswas N. Optic disc in fundus coloboma. Ophthalmology103, 2120–2126 (1996).
  • Vedantham V. Double optic discs, optic disc coloboma, and pit: spectrum of hybrid disc anomalies in a single eye. Arch. Ophthalmol.123, 1450–1451 (2005).
  • Vogt G, Puho E, Czeizel AE. A population-based case–control study of isolated ocular coloboma. Ophthalmic Epidemiol.12, 191–197 (2005).
  • Porges Y, Gershoni-Baruch R, Leibu R et al. Hereditary microphthalmia with colobomatous cyst. Am. J. Ophthalmol.114, 30–34 (1992).
  • Hornby SJ, Adolph S, Gilbert CE, Dandona L, Foster A. Visual acuity in children with coloboma: clinical features and a new phenotypic classification system. Ophthalmology107, 511–520 (2000).
  • MacDonald AE. Causes of blindness in Canada: an analysis of 24,605 cases registered with the Canadian National Institute for the Blind. Can. Med. Assoc. J.92, 264–279 (1965).
  • Traboulsi EI. Colobomatous microphthalmia, anophthalmia, and associated malformation syndromes. In: Genetic Diseases of the Eye. Traboulsi EI (Ed.). Oxford University Press, NY, USA, 51–80 (1999).
  • Hornby SJ, Ward SJ, Gilbert CE. Eye birth defects in humans may be caused by a recessively-inherited genetic predisposition to the effects of maternal vitamin A deficiency during pregnancy. Med. Sci. Monit.9, 23–26 (2003).
  • Miller MT, Stromland K. Teratogen update – thalidomide: a review, with a focus on ocular findings and new potential uses. Teratology60, 306–321(1999).
  • Stromland K, Pinazo-Duran MD. Ophthalmic involvement in the fetal alcohol syndrome: clinical and animal model studies. Alcohol Alcohol.37, 2–8 (2002).
  • Meins M, Burfeind P, Motsch S et al. Partial trisomy of chromosome 22 resulting from an interstitial duplication of 22q112 in a child with typical cat eye syndrome. J. Med. Genet.40, E62 (2003).
  • Russell-Eggitt I, Blake K, Taylor D, Wyse R. The eye in CHARGE association. Br. J. Ophthalmol.74, 421–426 (1990).
  • Lalani SR, Safiullah AM, Fernbach SD et al. Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am. J. Hum. Genet.78, 303–314 (2006).
  • Issekutz KA, Graham JM Jr, Prasad C, Smith IM, Blake KD. An epidemiological analysis of CHARGE syndrome: preliminary results from a Canadian study. Am. J. Med. Genet.133, 309–317 (2005).
  • Vissers LELM, van Ravenswaaji CMA, Admiraal R et al. Mutations in a new member of the chromodomain family cause CHARGE syndrome. Nat. Genet.36, 955–957 (2004).
  • Jongmans MC, Admiraal RJ, Van der Donk KP et al. CHARGE syndrome: thephenotypic spectrum of mutations in the CHD7 gene. J. Med. Genet.43, 306–314 (2006).
  • Hornby SJ, Dandona L, Jones RB, Stewart H, Gilbert CE. The familial contribution to non-syndromic ocular coloboma in South India. Br. J. Ophthalmol.87, 336–340 (2003).
  • WHO. Global Prevalence of Vitamin A Deficiency Monograph. WHO, Geneva, Switzerland (1995).
  • Hornby SJ, Ward SJ, Gilbert CE, Dandona L, Foster A, Jones RB. Environmental risk factors in congenital malformations of the eye. Ann. Trop. Paediatr.22, 67–77 (2002).
  • Wilson JG, Roth CB, Warkany J. An analysis of the syndrome of malformations induced by maternal vitamin A deficiency: effects of restoration of vitamin A at various times during gestation. Am. J. Anat.92, 189–217 (1953).
  • Seeliger MW, Biesalski HK, Wissinger B et al. Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest. Ophthalmol. Vis. Sci.40, 3–11 (1999).
  • Stromland K, Miller MT. Thalidomide embryopathy: revisited 27 years later. Acta Ophthalmol. (Copenh.)71, 238–245 (1993).
  • Castilla EE, Ashton-Prolla P, Barreda-Mejia E et al. Thalidomide, a current teratogen in South America. Teratology54, 273–277 (1996).
  • Stromland K, Pinazo-Duran MD. Optic nerve hypoplasia. Comparative effects in shildren and rats exposed to alcohol during pregnancy. Teratology50, 100–111 (1994).
  • Stromland K, Hellstrom A. Fetal alcohol syndrome: an ophthalmological and socioeducational prospective study. Paediatrics97, 845–850 (1996).
  • Aramaki M, Hokuto I, Matsumoto T et al. Iridic and retinal coloboma associated with prenatal methimazole exposure. Am. J. Med. Genet.139, 156–158 (2005).
  • Kroes HY, Reefhuis J, Cornel MC. Is there an association between maternal carbamazepine use during pregnancy and eye malformations in the child? Epilepsia43, 929–931 (2002).
  • Hampton GR, Krepostman JI. Ocular manifestations of the fetal hydantoin syndrome. Clin. Pediatr.20, 475–478 (1981).
  • Apple DJ, Bennett TO. Multiple systemic and ocular malformations associated with maternal LSD usage. Arch. Ophthalmol.92, 301–303 (1974).
  • Anteby I, Cohen E, Anteby E, BenEzra D. Ocular manifestations in children born after in vitro fertilisation. Arch. Ophthalmol.119, 1525–1529 (2001).
  • Hittner HM, Desmond MM, Montgomery JR. Optic nerve manifestations of human congenital cytomegalovirus infection. Am. J. Ophthalmol.81, 661–665 (1976).
  • Suhardjo, Utomo PT, Agni AN. Clinical manifestations of ocular toxoplasmosis in Yogyakarta, Indonesia: a clinical review of 173 cases. Southeast Asian. J. Trop. Med. Public Health34, 291–297 (2003).
  • Nielson JN, Carlton WW. Colobomatous microphthalmos in a New Zealand white rabbit, arising from a colony with suspected vitamin E deficiency. Lab. Anim. Sci.45, 320–322 (1995).
  • Kuno H, Kemi M, Matsumoto H. Critical period for induction of ocular anomalies produced by soft x-ray irradiation (4.6 Gy) in the rat F1 offspring. Jikken. Dobutsu.43, 115–119 (1994).
  • Edwards MJ. Hyperthermia as a teratogen: a review of experimental studies and their clinical significance. Teratog. Carcinog. Mutagen6, 563–582 (1986).
  • Colson A, Lederer J, Michiels J. Ocular lesions induced by saccharin and its pollutants in the rat fetus. J. Fr. Ophthalmol.7, 399–410 (1984).
  • Hauptman O, Albert DM, Plowman MC, Hopfer SM, Sunderman FW Jr. Ocular malformations of Xenopus laevis exposed to nickel during embryogenesis. Ann. Clin. Lab. Sci.23, 397–406 (1993).
  • Torres M, Gómez-Pardo E, Gruss P. Pax2 contributes to inner ear patterning and optic nerve trajectory. Development122, 3381–3391 (1996).
  • Hallonet M, Hollemann T, Pieler T, Gruss P. Vax1, a novel homeobox-containing gene, directs development of the basal forebrain and visual system. Genes Dev.13, 3106–3144 (1999).
  • Stadler JA, Shkumatava A, Neumann CJ. The role of hedgegog signalling in the development of the zebrafish visual system. Dev. Neurosci.26, 346–351 (2004).
  • Cohen MM. The hedgehog signalling network. Am. J. Med. Genet.123A, 5–28 (2003).
  • Macdonald R, Barth KA, Xu Q, Holder N, Mikkola I, Wilson SW. Midline signalling is required for Pax gene regulation and patterning of the eyes. Development121, 3267–3278 (1995).
  • Take-uchi M, Clarke JD, Wilson SW. Hedgehog signalling maintains the optic stalk-retinal interface through the regulation of Vax gene activity. Development130, 955–968 (2003).
  • Schell-Apacik C, Rivero M, Knepper JL, Roessler E, Muenke M, Ming JE. Sonic hedgehog mutations causing human holoprosencephaly impair neural patterning activity. Hum. Genet.113(2), 170–177 (2003).
  • Chiang C, Litingtung Y, Lee E et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature383, 407–413 (1996).
  • Schimmenti LA, de la Cruz J, Lewis RA et al. Novel mutation in Sonic hedgehog in non-syndromic colobomatous microphthalmia. Am. J. Med. Genet.116A, 215–221 (2003).
  • Eccles MR, Schimmenti LA. Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations. Clin. Genet.56, 1–9 (1999).
  • Dureau P, Attie-Bitach T, Saloman R et al. Renal Coloboma Syndrome. Ophthalmology108, 1912–1916 (2001).
  • Mui SH, Kim JW, Lemke G, Bertuzzi S. Vax genes ventralise the embryonic eye. Genes Dev.19, 1249–1259 (2005).
  • Barbieri AM, Broccoli V, Bovolenta P et al. Vax2 inactivation in mouse determines alteration of the eye dorsal–ventral axis, misrouting of the optic fibres and eye coloboma. Development129, 805–813 (2002).
  • Hever AM, Williamson KA, van Heyningen V. Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2. Clin. Genet.69, 459–470 (2006).
  • Ashery-Padan R, Marquardt T, Zhou X, Gruss P. Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev.14, 2701–2711 (2000).
  • Ton CC, Hirvonen H, Miwa H, et al. Positional cloning and characterisation of a paired box and homeobox-containing gene for the aniridia region. Cell67, 1059–104 (1991).
  • Hanson IM. PAX6 and congenital eye malformations. Paediatr. Res.54, 791–96 (2003).
  • Azuma N, Yamaguchi Y, Handa H, et al. Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations. Am. J. Hum. Genet.72, 1565–1570 (2003).
  • Baulmann DC, Ohlmann A, Flügel-Koch C, Goswami S, Cvekl A, Tamm ER. Pax6 heterozygous eyes show defects in chamber angle differentiation that are associated with a wide spectrum of other anterior eye segment abnormalities. Mech. Dev.118, 3–17 (2002).
  • Zuber ME, Gestri G, Viczian AS, Barsacchi G, Harris WA. Specification of the vertebrate eye by a network of eye field transcription factors. Development130, 5155–5167 (2003).
  • Wallis DE, Roessler E, Hehr U et al. Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly. Nat. Genet.22, 196–198 (1999).
  • Lagutin OV, Zhu CC, Kobayashi D et al. Six3 repression of Wnt signaling in the anterior neuroectoderm is essential for vertebrate forebrain development. Genes Dev.17, 368–379 (2003).
  • Del Bene F, Tessmar-Raible K, Wittbrodt J. Direct interaction of geminin and Six3 in eye development. Nature427, 745–749 (2004).
  • Wargelius A, Seo HC, Austbo L, Fjose A. Retinal expression of zebrafish six3.1 and its regulation by Pax6. Biochem. Biophys. Res. Commun.309, 475–481 (2003).
  • Ferda-Percin E, Ploder LA, Yu JJ et al. Human microphthalmia associated with mutations in the retinal homeobox gene CHX10. Nat. Genet.25, 397–401 (2000).
  • Green ES, Stubbs JL, Levine EM. Genetic rescue of cell number in a mouse model of microphthalmia: interactions between Chx10 and G1-phase cell cycle regulators. Development130, 539–552 (2003).
  • Jamieson RV, Perveen R, Kerr B et al. Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma. Hum. Mol. Genet.11, 33–42 (2002).
  • Kim JI, Li T, Ho IC, Grusby MJ, Glimcher LH. Requirement for the c-Maf transcription factor in crystallin gene regulation and lens development. Proc. Natl Acad. Sci. USA96, 3781–3785 (1999).
  • Sakai M, Serria MS, Ikeda H, Yoshida K, Imaki J, Nishi S. Regulation of c-maf gene expression by Pax6 in cultured cells. Nucleic Acids Res.29, 1228–1237 (2001).
  • Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark AF. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol. Vis.8, 241–250 (2002).
  • Dunn NR, Winnier GE, Hargett LK, Schrick JJ, Fogo AB, Hogan BL. Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev. Biol.188, 235–247 (1997).
  • Adler R, Belecky-Adams TL. The role of bone morphogenetic proteins in the differentiation of the ventral optic cup. Development129, 3161–3171 (2002).
  • Jena N, Martin-Seisdedos C, McCue P, Croce CM. BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp. Cell. Res.230, 28–37 (1997).
  • Morcillo J, Martinez-Morales JR, Trousse F et al. Proper patterning of the optic fissure requires subsequential activity of BMP7 and SHH. Development133, 3179–3190 (2006).
  • Groppe J, Greenwald J, Wiater E et al. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature420, 636–642 (2002).
  • Sharov AA, Weiner L, Sharova TY et al. Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J.22, 2992–3003 (2003).
  • Bachiller D, Klingensmith J, Kemp C et al. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature403, 658–661 (2000).
  • Weston CR, Wong A, Hall JP, Goad ME, Flavell RA, Davis RJ. JNK initiates a cytokine cascade that causes Pax2 expression and closure of the optic fissure. Genes Dev.17, 1271–1280 (2003).
  • Hyatt GA, Schmitt EA, Marsh-Armstrong N, McCaffery P, Drager UC, Dowling JE. Retinoic acid establishes ventral retinal characteristics. Development122, 195–204 (1996).
  • Sasagawa S, Takabatake T, Takabatake Y, Muramatsu T, Takeshima K. Axes establishment during eye morphogenesis in Xenopus by coordinate and antagonistic actions of BMP4, Shh and RA. Genesis33, 86–96 (2002)
  • Helms JA, Kim CH, Hu D, Minkoff R, Thaller C, Eichele G. Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid. Dev. Biol.187, 25–35 (1997).
  • Hahn H, Wicking C, Zaphiropoulos PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell85, 841–851 (1996).
  • Huh S, Hatini V, Marcus RC, Li SC, Lai E. Dorsal-ventral patterning defects in the eye of BF-1-deficient mice associated with a restricted loss of shh expression. Dev. Biol.211, 53–63 (1999)
  • Gregory-Evans CY, Vieira H, Dalton R, Adams GG, Salt A, Gregory-Evans K. Ocular coloboma and high myopia with Hirschsprung disease associated with a novel ZFHX1B missense mutation and trisomy 21. Am. J. Med. Genet.131, 86–90 (2004).
  • You L, Kruse FE. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest. Ophthamol. Vis. Sci.43, 72–81 (2002).
  • Fantes J, Ragge NK, Lynch SA et al. Mutations in SOX2 cause anophthalmia. Nat. Genet.33, 461–462 (2003).
  • Dollfus H, Biswas P, Kumaramanickavel G et al. Saethre-Chotzen syndrome: notable intrafamilial phenotypic variability in a large family with Q28X TWIST mutation. Am. J. Med. Genet.109, 218–225 (2002).
  • Gradstein L, Belfair N, Ronen E, Lifshitz T, Biedner BZ. Functional vision loss in patients with bilateral ocular coloboma. JAAPOS6, 195–197 (2002).
  • Burk SE, Da Mata AP, Snyder ME, Cionni RJ, Cohen JS, Osher RH. Prosthetic iris implantation for congenital, traumatic, or functional iris deficiencies. J. Cataract Refract. Surg.27, 1732–1740 (2001).
  • Pal N, Azad RV, Sharma YR. Long-term anatomical and visual outcome of vitreous surgery for retinal detachment with choroidal coloboma. Indian J. Ophthalmol.54, 85–88 (2006).
  • Spitzer M, Grisanti S, Bartz-Schmidt KU, Gelisken F. Choroidal neovascularisation in retinochoroidal coloboma: thermal laser treatment achieves long-term stabilization of visual acuity. Eye20, 969–972 (2006).
  • Gouya L, Puy H, Robreau AM et al. Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum. Genet.114, 256–262 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.